Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V9QR
|
||||
Former ID |
DNC000244
|
||||
Drug Name |
Apricitabine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Phase 3 | [522332] | ||
Structure |
Download2D MOL |
||||
Formula |
C8H11N3O3S
|
||||
Canonical SMILES |
C1C(SC(O1)CO)N2C=CC(=NC2=O)N
|
||||
InChI |
1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m1/s1
|
||||
InChIKey |
RYMCFYKJDVMSIR-RNFRBKRXSA-N
|
||||
CAS Number |
CAS 160707-69-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | HIV reverse transcriptase | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.